GSTP1 directly binds to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and activates its glycolytic enzyme function in triple-negative breast cancer cells, as demonstrated by pharmacological inactivation [77]. Here, GAPDH is linked to triple-negative breast carcinoma.